James T. McCarthy, M.D., is a clinical nephrologist with a primary focus of improving survival and quality of life for patients with chronic kidney disease, primarily those receiving chronic dialysis.
His studies generally revolve around analysis of patient outcomes and factors that impact these outcomes. Dr. McCarthy also participates in interventional trials that support his areas of focus.
Significance to patient care
Dr. McCarthy's investigations will help decrease hospitalization, improve survival and lead to higher quality of life for patients with chronic kidney disease.
Nearly 500,000 patients are on dialysis or have kidney transplants in the U.S., and there may be up to 10 million to 20 million patients in the U.S. with significant chronic kidney disease that would benefit by improvements in these areas.
- Chair, Division of Nephrology & Hypertension, Mayo Clinic in Rochester, Minn., 2009-present
- Member, Board of Directors, Mayo Clinic Health System, 2001-2010
- Chair and/or Member, Medical Review Committee, ESRD Network 11, 1990-2009
- Chair (physician leader), Mayo Clinic Health System Electronic Medical Record (EMR) Oversight Group, 2005-2009
- Member, Medical Advisory Council, National Forum of ESRD Networks, 2006-2009
- Clinical Director, Technical Expert Panel for Clinical Performance Measures for Bone and Mineral Disorders in End-Stage Renal Disease, 2004-2005
- Member, National Kidney Foundation Workgroup for Development of Guidelines for Kidney Disease Outcome Quality Initiative (K-DOQI) for Bone Disease, 2000-2003
See my publications
- Professor of Medicine
- Fellow - Nephrology Mayo Graduate School of Medicine, Mayo Clinic College of Medicine
- Resident - Internal Medicine Mayo Graduate School of Medicine, Mayo Clinic College of Medicine
- MD University of Kansas Medical School
- BA - Biochemistry, with honors University of Kansas